By 2030, 5 Ways to Improve Cancer Treatment

We expect important cancer advances over the next 10 years: personalized treatments, immunotherapies, drug combinations, new technologies, decision-support systems, and electronic health record solutions enabling real-time patient monitoring... In 2018, there were 18 million new diagnoses and 9.6 million cancer deaths worldwide (see cancer statistics). Aging populations are expected to increase these figures. Emerging treatments and technology offer hope to patients and families. Here are approaches over the next 10 years: 5 ways to improve treatment.
More Targeted / Precision Cancer Treatments
Conventional chemotherapy has long been standard systemic cancer treatment. However, targeted therapy is an increasingly used, more precise and personalized approach. Unlike chemotherapy that may harm both normal and cancer cells, targeted treatments “mostly” disrupt cancer cells with fewer effects on healthy cells. They achieve this by targeting specific genetic features that distinguish cancer cells, then inhibiting proliferation. Genetic tests, such as ALK, EGFR, KRAS, and NTRK, are therefore needed to assess many targeted drugs' suitability. Some also classify immunotherapies as targeted drugs, triggering patients' immunity to kill cancer cells. Others block growth factors instructing cancer cells to grow and divide. The prescribed therapy depends on cancer type and genetic changes. This personalization increases response likelihood and identifies people unlikely to benefit.
Technology Will Guide Doctors' Decisions
New technologies will change how doctors treat and interact with patients over the next decade. Artificial intelligence (AI) is expected soon, rather than “waiting several months” to predict treatment response, to provide doctors for each patient with information about the best treatment plans . This is particularly important for patients unable to wait several months.
- Related Topics: - In which field has artificial intelligence become better than doctors? - Predicting whether you will develop breast cancer in the future using artificial intelligence
Emphasis on Early Diagnosis and Cancer Risks
According to Western societies' projections, in the USA and Canada, of every 10 people, 4-5 will receive a cancer diagnosis during life. Identifying higher-risk individuals will become a priority over the next 10 years. Public education comes first: do not smoke, use sunscreen, watch obesity, eat mainly vegetables, and make exercise a lifestyle. Risk awareness remains critical, while early-detection technologies, such as liquid blood biopsies, matter increasingly for higher-risk groups. - Related topic: The 8 most preventable cancer types. Identifying high-risk individuals allows better biomarkers, diagnosis, and interventions.
A Team-Based Approach Is Becoming More Important
In cancer treatment, a multidisciplinary approach will become more widespread in coming years. Centers adopting it will offer better treatments. Medical oncologists, surgeons, radiation oncologists, palliative specialists, and oncology nurses work together to guide care. This matters because new effective treatments are more accessible, yet numerous complications, medical problems from disease or treatment, may occur. Care in a setting where all specialists discuss the best path is important at every treatment stage.
Treatment Costs Must Not Be Ignored, and National and International Solutions Must Ensure Equitable Access
Cancer weakens not only physical but financial health. According to the US National Cancer Institute, average treatment costs are approximately 150.000 dollars per patient , and in 2020 the USA alone is expected to spend on cancer care 174 billion dollars . Cost increasingly obstructs access. Targeted drugs, immunotherapies, CDK 4-6 inhibitors, PARP inhibitors... each is expensive. Inability to pay can cause financial distress and worse outcomes even after cancer survival. Over the next 10 years, cost is another essential issue to address.
Conclusion
Within 10-20 years, we envision many cancers detected and treated early, AI-based decision-support systems recommending effective treatments based on genetic information, and mobile applications monitoring symptoms in real time for timely interventions. This could save time and money. We are not there yet, but it is our vision.
Was this article helpful?
Your feedback helps us improve our content.





Reader comments
Share your comment
Your name and comment are published only after administrator approval. Your email address is never shown to visitors.
Be the first to comment.